The FDA announced on April 14, 2014, that Upsher-Smith Laboratories recalled Oxandrolone Tablets USP 10 mg due to missing primary labels. The agency stated the recall was voluntary and involved 1,185 bottles distributed nationwide.
How to tell if you have it
- Brand: Upsher-Smith
- Product: Oxandrolone Tablets USP 10 mg
- NDC: 0245-0272-06
- Lot #: 2802.042A
- Expiration: 10/2015
- Packaging: 60-count bottle
The hazard
According to the FDA, three cases totaling 36 bottles were packaged without primary labels on the bottle. These cases were sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
Context
GovInfoNow's records show Upsher Smith Laboratories has issued four other recalls since November 20, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint (January 21, 2026).